An asymptomatic patient with multiple solid renal masses: errors in diagnosis.

Caterina Canavese; Laura Rizzo; Paolo Aveta; Federico Cesarani; Giuseppe Isolato; Giancarlo Anselmetti; Giorgio Passarino; Ottavio Davini; Donatella Pacchioni; Paola Cassoni; Daniela Bergamo; Piero Stratta

doi:10.1093/ndt/gfh943

PubMed · 16030054

An asymptomatic patient with multiple solid renal masses: errors in diagnosis.

Caterina Canavese·Laura Rizzo·Paolo Aveta·Federico Cesarani·Giuseppe Isolato·Giancarlo Anselmetti·Giorgio Passarino·Ottavio Davini·Donatella Pacchioni·Paola Cassoni·Daniela Bergamo·Piero Stratta

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Adenoma, Oxyphilic Biopsy Diagnostic Errors Humans Kidney Neoplasms Male Middle Aged Prostatectomy Pyelonephritis, Xanthogranulomatous Case Reports Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Caterina Canavese, Laura Rizzo, Paolo Aveta, Federico Cesarani, Giuseppe Isolato, Giancarlo Anselmetti, Giorgio Passarino, Ottavio Davini, Donatella Pacchioni, Paola Cassoni, Daniela Bergamo, Piero Stratta. 2005-07-19. An asymptomatic patient with multiple solid renal masses: errors in diagnosis.. https://doi.org/10.1093/ndt%2Fgfh943

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

ARPP protein is selectively expressed in renal oncocytoma, but rarely in renal cell carcinomas.

We have recently isolated a gene, Ankyrin-repeated protein with a proline-rich region (ARPP), that is highly expressed in the skeletal and cardiac muscle. Our previous immunohistochemical analysis revealed that ARPP expression was augmented in rhabdomyosarcoma but scarcely detectable in leiomyosarcoma, showing that ARPP is a useful marker for rhabdomyosarcoma. In the present study, we generated the anti-ARPP monoclonal antibody, YAS11, immunoreactive with the N-terminal region (amino-acids residues 1-145) of the ARPP protein. Further, we immunohistochemically analyzed 100 renal tumors including 14 oncocytomas, and 86 renal cell carcinomas (RCCs). We found that ARPP was highly expressed in 12 of the 14 (85.7%) oncocytomas, but was detectable in only four of the 86 (4.7%) RCCs. Interestingly, ARPP was not detected in any of 11 chromophobe RCCs, suggesting that ARPP may be useful for differential diagnosis between oncocytoma and chromophobe RCC. Furthermore, we found that ARPP was selectively expressed in part of the distal renal tubule in normal kidney. Immunoelectron microscopy with anti-ARPP antibody revealed that ARPP was localized in mitochondria and nuclei in both the normal distal renal tubule and oncocytoma, suggesting that oncocytoma may be derived from the distal nephron, and probably from part of the distal renal tubule.

Adenoma, Oxyphilic↗

PubMed2007

Oncocytic meningioma: report of a case with progression after radiosurgery.

Oncocytic meningioma is an uncommon variant of meningioma, characterized histologically by cells rich in mitochondria. This subtype of meningioma needs to be distinguished from other types of meningioma because of its more aggressive behavior. A case of oncocytic meningioma showing rapid clinical progression with diffuse intracranial dissemination after radiosurgery is described. Resistance to radiotherapy has been previously reported in oncocytic tumors of various body sites. This new case is a further example of the greater aggressiveness of oncocytic meningioma, suggesting that radiation therapy might worsen the course of disease.

Adenoma, Oxyphilic↗

PubMed2007

Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma.

Immunohistochemical staining for cytokeratin 7 (CK7), KIT, and PAX2 expression was performed on 91 renal neoplasms, 37 conventional (clear cell) renal cell carcinomas (CRCCs), 20 papillary RCCs (PRCCs), 11 chromophobe RCCs (ChCs), and 23 oncocytomas, with available karyotypes. All ChCs, 19 PRCCs, 2 CRCCs, and 1 oncocytoma were CK7+; all ChCs, 22 oncocytomas, 2 CRCCs, and no PRCCs expressed KIT; PAX2 was positive in 31 CRCCs, 17 PRCCs, 20 oncocytomas, and 1 ChC. The predominant expression profiles were as follows: CRCC, CK7-/KIT-/PAX2+ (26/37); PRCC, CK7+/KIT-/PAX2+ (17/20); ChC, CK7+/KIT+/PAX2- (10/11); and oncocytoma, CK7-/KIT+/PAX2+ (19/23). Cytogenetic analysis showed that the sole PAX2+ ChC had a retained chromosome 10, and all ChCs with chromosome 10 loss were PAX2-. These results identify specific staining patterns of the 4 major histologic subtypes of renal neoplasms and raise the question of a relationship between chromosome 10 loss and loss of PAX2 expression in ChC.

Adenoma, Oxyphilic↗